Literature DB >> 23212754

Peripheral neuropathy as initial manifestation of primary systemic vasculitides.

Joachim Wolf1, Verena Schmitt, Frederic Palm, Armin J Grau, Raoul Bergner.   

Abstract

Peripheral neuropathies are well-known complications of primary systemic vasculitides. In rare cases, peripheral neuropathies are among the first symptoms of these diseases. In this prospective study, 89 consecutive adult patients with newly diagnosed primary systemic vasculitis were screened, of whom 22 patients (25 %, 12 men, ten women, mean age, 59 years, range, 26-82 years) suffered from peripheral neuropathy due to systemic vasculitis at initial presentation. Peripheral neuropathy was most frequent in newly diagnosed patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome, 12 out of 20 patients, 60 %) and polyarteritis nodosa (three out of six patients, 50 %), and less common in patients with granulomatosis with polyangiitis (six out of 47 patients, 13 %) and microscopic polyangiitis (one out of 16 patients, 6 %). Multiplex mononeuropathy was more frequent (n = 13, 59 %) than symmetric polyneuropathy (n = 9, 41 %). The nerves commonly affected were the peroneal nerve, followed by the sural, posterior tibial, and median nerves. Treatment options were chosen according to current guidelines of the national neurological and rheumatologic societies, with initial corticosteroid monotherapy for patients with a mild disease form and a combination of corticosteroids and intravenously pulsed cyclophosphamide for patients with a more extended organ involvement. During follow-up (mean, 34 months, range, 12-112 months), new neurological complications were rare (9 %): One patient suffered from a cerebral infarct while another patient sustained epileptic seizures. Two patients (9 %) died from sepsis (after 60 months) or severe gastrointestinal bleeding (after 13 months). The degree of neurological disability measured by the functional disability score (described by Prineas) improved in 20 of 22 patients after 12 months of therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212754     DOI: 10.1007/s00415-012-6760-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

Review 1.  Primary and secondary vasculitic neuropathy.

Authors:  Gérard Said; Catherine Lacroix
Journal:  J Neurol       Date:  2005-04-05       Impact factor: 4.849

2.  Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

Authors:  Christian Pagnoux; Raphaèle Seror; Corneliu Henegar; Alfred Mahr; Pascal Cohen; Véronique Le Guern; Boris Bienvenu; Luc Mouthon; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2010-02

3.  Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre.

Authors:  A Della Rossa; C Baldini; A Tavoni; A Tognetti; D Neglia; G Sambuceti; R Puccini; C Colangelo; S Bombardieri
Journal:  Rheumatology (Oxford)       Date:  2002-11       Impact factor: 7.580

4.  "Pseudo-conduction block" in vasculitic neuropathy.

Authors:  L McCluskey; D Feinberg; C Cantor; S Bird
Journal:  Muscle Nerve       Date:  1999-10       Impact factor: 3.217

5.  Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.

Authors:  Ravi Suppiah; Robert D M Hadden; Rajbir Batra; Nigel K Arden; Michael P Collins; Loic Guillevin; David R W Jayne; Raashid A Luqmani
Journal:  Rheumatology (Oxford)       Date:  2011-09-02       Impact factor: 7.580

6.  Vasculitis confined to peripheral nerves.

Authors:  L Davies; J M Spies; J D Pollard; J G McLeod
Journal:  Brain       Date:  1996-10       Impact factor: 13.501

7.  Neurologic complications of Churg-Strauss syndrome--a prospective monocentric study.

Authors:  J Wolf; R Bergner; S Mutallib; F Buggle; A J Grau
Journal:  Eur J Neurol       Date:  2009-12-27       Impact factor: 6.089

8.  Usefulness of superficial peroneal nerve/peroneus brevis muscle biopsy in the diagnosis of vasculitic neuropathy.

Authors:  J B Agadi; Govindarajan Raghav; A Mahadevan; S K Shankar
Journal:  J Clin Neurosci       Date:  2012-08-15       Impact factor: 1.961

Review 9.  Pathophysiology of ANCA-associated small vessel vasculitis.

Authors:  Cees G M Kallenberg
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

10.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11
View more
  4 in total

1.  Peroneal nerve involvement as initial manifestation of primary systemic vasculitis.

Authors:  Paolo Ripellino; Claudia Varrasi; Elena Maldi; Roberto Cantello
Journal:  BMJ Case Rep       Date:  2014-03-31

Review 2.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

3.  Eosinophilic Granulomatosis with Polyangiitis Presenting as Acute Polyneuropathy Mimicking Guillain-Barre Syndrome.

Authors:  Carlos R Camara-Lemarroy; Adrian Infante-Valenzuela; Hector J Villareal-Montemayor; Carlos A Soto-Rincon; Javier A Davila-Olalde; Hector J Villareal-Velazquez
Journal:  Case Rep Neurol Med       Date:  2015-06-23

4.  A case of left foot drop as initial symptom of granulomatosis with polyangiitis: Triggered by COVID-19 disease?

Authors:  Marjolaine Weynand; Ioannis Raftakis; Yassine Mohammad Chérif; Sophie Lecomte; Valérie Badot
Journal:  Clin Case Rep       Date:  2022-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.